Vaccine margins are probably lower for the flu where you have to gear up for new strains every year, but all in all vaccines are a great business to be in bc margins are high and there is no patent cliff and there is a higher barrier to entry compared to traditional drugs. There is of course commercial risk e.g. if someone comes along w a better version of vaccine